SCHEMBL7927928

SCHEMBL7927928

COc1cc(C(O)CNC(=O)c2ccc([N+](=O)[O-])cc2Cl)cc(OC)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.49
HPGD P15428 1/20 0.49
PYGL P06737 1/20 0.48
PKM P14618 2/20 0.48
MAPT P10636 5/20 0.47
NPC1 O15118 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HTT P42858 2/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.47
MCL1 Q07820 1/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
GAA P10253 3/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 2/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7932806 0.88 MAPT (0.47) PKMMAPTNPC1SMN1; SMN2KDM4E
SCHEMBL7929624 0.75 NR4A2 (0.44) TP53MAPTPOLB
SCHEMBL3099561 0.73 RAB9A (0.62) TP53HPGDMAPTNPC1SMN1; SMN2
SCHEMBL1706973 0.73 MEN1 (0.62) TP53PKMMAPTNPC1SMN1; SMN2
SCHEMBL10126508 0.71 NPC1 (0.67) TP53PKMMAPTNPC1SMN1; SMN2
SCHEMBL7930108 0.71 KMT2A (0.57) TP53NPC1LMNARAB9APOLB
SCHEMBL1645411 0.70 MEN1 (0.58) TP53PKMMAPTSMN1; SMN2HTT
SCHEMBL4640437 0.70 MAPT (0.54) PKMMAPTNPC1SMN1; SMN2HTT
SCHEMBL11676127 0.69 KMT2A (0.69) TP53HPGDMAPTNPC1SMN1; SMN2
SCHEMBL7566341 0.69 MAPT (0.66) TP53HPGDMAPTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228868-B1 ANTICARCINOGENIC AND ANTITUMOR AGENTS ABBOTT LABORATORIES 2001-05-08 US disclosed